Posts Tagged ‘IBM Cognos’

Buy Zometa Online Cheap

screen-shot-2010-04-05-at-13101-amscreen-shot-2010-04-17-at-54829-pm

Oracle Adds A Trusted CTMS/EDC Solution To Its Health Sciences Portfolio
Buy zometa online cheap, On April 16th, Oracle announced its intent to acquire Phase Forward, a Cambridge, Massachusetts based Clinical Trials Management Software (CTMS) vendor and early electronic data capture (EDC) pioneer.  Phase Forward adds 335 life science, medical device, research agency, and contract research organization (CRO) customers to Oracle's portfolio.  The PhaseForward acquisition makes sense for Oracle because:



  • Oracle Health Sciences lacks a strong CTMS component. CTMS solutions streamline clinical development operations to manage multiple trials.  As the information and management hub, a CTMS often orchestrates information and processes from EDC, Wyoming WY Wyo., clinical data management system (CDMS), Zometa prescription, adverse event reporting systems (AERS), interactive voice response systems (IVRS), and other reporting and statistical solutions (see Figure 1).  Oracle's existing solutions focus more on components such as drug discovery, köpa cytoxan, EDC, Purchase epogen online, adverse event reporting system (AERS), and some statistical analysis.  Phase Forward brings together a series of clinical data solutions, randomization and trial supply management, buy zometa pill, Phase 1 clinic automation, Kjøpe billig iressa, safety solutions, clinical development center, late phase and ePRO solutions, order cytoxan online cheap, and CDISC standards.



  • Customers seek an integrated offering. Life science companies face competing pressures to bring solutions to market and to address patent expiration.  With the skyrocketing costs of bringing new products to market, existing Oracle customers and prospects seek the "holy grail" of one integrated offering to reduce costs, manage risk, and provide insight into future innovations, buy zometa online cheap. Cheap gleevec no prescription, Unfortunately, today's customers must turn to different solutions for drug discovery, pre-clinical testing, αγοράζουν φτηνά epogen, Phase 1, Köpa capecitabine, Phase 2, Phase 3, FDA Review/approval, ordering evista, post market testing, Colorado CO Colo., and safety monitoring and reporting.


Figure 1.  Key Processes For CTMS

screen-shot-2010-04-17-at-62409-pm

The Bottom Line For Customers - Be Vigilant. Ask Tons Of Questions.

Overall, cheap arimidex, customers should see long term synergies and benefit from this acquisition.  Oracle has proven itself with a strong track record of organizational integration.  Product integration success has been positive but not fully proven.  Given both Phase Forward and Oracle's myriad of product lines, Om evista online, customers should focus questions to Oracle about:


  • Integration with existing acquisitions. Understand the existing Oracle and Phase Forward landscape. Buy zometa online cheap, Determine where you'll benefit from existing acquisitions and understand the solution overlaps.  Determine how other products such as Oracle Thesaurus Management System, Oracle Healthcare Transaction Base, and Argus Safety Suite can play a role in future solution road maps.

  • Long term product direction. Ask executives for their vision of the future.  Don't be shy and ask where Oracle sees their gaps and ask them how they intend to fill these holes in the solution footprint.  Determine how the Phase Forward SaaS platform will merge with Oracle's.

  • Future investment levels, Michigan MI Mich.. Seek commitments on future R&D investment levels.  Ask how service and support staff will be transitioned.  Find out which executives have received golden handcuffs and which have been asked to leave.

  • Licensing and pricing policies. Kjøpe billig zometa, Oracle traditionally moves maintenance pricing to 22%.  Find out what policies will be changed to meet Oracle's standard policies.  Existing customers should seek longer term guarantees by extending maintenance contracts before the acquisition closes.


The Bottom Line For Vendors - Expect Oracle To Keep Acquiring In Life Sciences And Healthcare

Competitors can expect Oracle to continue its investments in Life Sciences and Healthcare.  The previous acquisition of Relsys International for Drug Safety and Risk Management only provided one component in the overall CTMS and EDC market.  Oracle's acquisition play book often starts with acquiring solutions with the highest value business processes and the largest base of maintenance paying customers in a vertical and micro vertical.  With a strong analytics backbone, CRM, ERP, Køb discount zometa, SCM, middleware, and database offerings, Oracle intends to win with a "one throat to choke" integrated offering.  Vendors competing in this space must forge new partnerships or consolidate in the next 3 to 5 years in order to compete against Oracle (see Figure 2).  Oracle believes it will be the only vendor with an end to end solution and hopes to capture the largest share of the Life Sciences and Healthcare budget.

Figure 2. Selected Competitors In The CTMS And EDC Market

screen-shot-2010-04-17-at-61104-pm

Your POV

What do you think about Oracle's acquisition strategy?  Are you a Phase Forward customer?  Do you have any other Oracle products?  Will you consider competitors or are you already "locked-in"?  Add your comments to the discussion or send on to rwang0 at gmail dot com or r at softwaresinsider dot org and we’ll keep your anonymity.

Please let us know if you need help with your overall apps strategy.  Here’s how we can help:


  • Assessing SaaS and cloud

  • Determining custom vs package

  • Assisting with legacy ERP migration

  • Evaluating middleware platforms

  • Planning upgrades and migration

  • Considering third party maintenance

  • Assisting with cost optimization

  • Performing vendor selection

  • Providing contract negotiations and software licensing support


Related resources and links
20100416 IDG News Service - Chris Kanaracus "Oracle Buying Drugs Trial Software Maker for $685M"

20100416 Paul Hamerman's Blog - Oracle Puts Another Notch In Its Industry Apps Acquisition Stick

20100416 ZDNet: Between The Lines - Larry Dignan "Oracle Buys Phase Forward"


Copyright © 2010 R Wang and Insider Associates, LLC. All rights reserved.

Similar posts: Order cheap capecitabine online. Order gleevec without prescription. Buy evista. Order evista. Comprare arimidex sconto.
Trackbacks from: Buy zometa online cheap. Buy zometa online cheap. Buy zometa online cheap. Hawaii HI. West Virginia WV W.Va..

Wednesday’s Whispers: The Word On the Street – April 2009

PEOPLE WHISPERS: MOVES, PROMOTIONS, AND MILESTONES* Congratulations to all!  Thanks for your emails and alerts.  If you’ve got a change or know of a promotion, keep dropping me a line!  If you need a referral, don't hesitate to reach out to me via Linked In. Richard Barnett joins Fine Solutions as a Vice President for Business Development.  Richard last served as the CMO at Kineticsware, Inc and served as an evangelist for the Microsoft Dynamics product lines as Director of Product Marketing. Alan Bowling leaves his post as CIO of Northern Foods and joins the Training and Development Agency for Schools as CIO.  Alan also serves as the Chairman of the very independent and influential SAP UK & Ireland Users Group. Max Efimov became Director of Emerging Technologies at SITA CORP in November 2008.  Previous roles include serving as a Manager of Enterprise Solutions - SAP for BearingPoint, Enterprise Solutions Architect at Tesoro Corp and Lead Systems Specialist at Valero Energy Corp. Bill Geist has been promoted to Executive Vice President of Services at CDC Software.  Bill formerly served as the SVP of Customer Services.  Bill brings a wealth of management consulting, staffing and professional services experiences with several senior roles as a Partner at Tatum, L.L.C., CEO of Application Partners, L.L.C., Senior Vice President for Headstrong, Inc., Partner of Whittman-Hart, Inc., Director at Cambridge Technology Partners, and VP of IT and Services for Scientific Atlanta. Aloke Ghosh has been appointed as the new CFO for Systime. Peter Graf is now Chief Sustainability Officer at SAP.  Peter served as the Executive Vice President for Marketing at SAP Labs. Allison Guidette became VP & GM at Thomson Reuters in January 2009.  Prior to Thomson Reuters, Allison served as Senior Vice President of Product Management at Merrill Corporation, Vice President of Business Law at Thomson West, and Senior Director at Corporate Executive Board. Christof Herzog became Manager Customer Segmentation Fachleiter Kundensegmentierung at Deutsche Telekom in January 2009.  Past roles include Principal Analyst at Vodafone and Senior Quantitative Analyst at Forrester Research. Indu Khattar brings strong operational experiences to SYSTIME as the COO.  Indu draws upon 2 decades of senior management experience with Fujitsu, ICIM, and Wipro Tom Kucharvy serves as the CEO at Beyond IT, Inc. in January 2009.  Tom bring a wealth of star analyst skills from Ovum where he was an Senior Vice President and from his experiences in building Summit Strategies as President and CEO. Norman Liang leaves Fox Interactive Media (Photobucket) to join stealth startup Fire-Exit.  Norm currently advises TripJane and the Martini Media Network.  Prior to Photobucket, Norm served a Business Development role at Nokia. Justin Mckenna is now a Business Development Representative at CIBER. Justin's experiences include roles as a Business Development Executive at One Technologies and Account Manager at Forrester Research. Vinay Nair joins IBM Cognos as an ERP market strategist.  At International Data Corporation (IDC), Vinay served as the Research Manager for the Canadian Enterprise Applications market and a Senior Research Analyst for the Middle East and Africa regions. Sean O'Neill leaves uTANGO to join GMI as Vice President of product and program management.  Sean has served executive roles in product management including seven years at Amazon.
Matt Pawl was promoted in March 2009 to Vice President of Marketing at Hayes Technology Group.  Matt previously was the marketing director. Anita Rao joins Symantec with the Global ERP Systems team.  Anita bring senior IT experiences from Visa, Garage Technology Ventures, Jamcracker, Oracle, Merrill Lynch, and Bear Stearns. Richard (Rick) Reidy has been promoted from COO to President and Chief Executive Officer (CEO) at Progress Software Corporation.  Reidy bring both a products and management background to the position. Joel Rosenberger joins GMI as Vice President of Engineering.  Joel bring experience from Amazon's Web Services team as well as roles as technical diplomat at Microsoft, CTO of TransLink Software, and Senior Architect at Attachmate. Dave Sampson takes on the role of Vice President for demand generation and customer experience at GMI's marketing strategies.  Dave was previously vice president of marketing for Sampa Corporation. Eilleen Shields takes on new responsibility as a Business Development Manager at Planpower a UXC company. Prior roles include senior sales positions with SAP, Forrester Research, and Jupiter Research. Michael Sotnick moved to ActivIdentity in December 2008.  As Executive Vice President of Worldwide Sales and Field Operations, Michael will put his sales, channel, and partner enablement experiences from SAP and Veritas to work. Chloe Stromberg is now a Senior Survey Research Manager at comScore, Inc. Chloe brings analytical and survey experience from work at IdeaLab and the University of Michigan. Mike Thoma became CTO and CMO at Blink Logic Inc. in December 2008. Previous experiences include roles as a special advisor to the CEO at Blink Logic and VP of Product Marketing at Actuate Corporation. Angus Thomson takes on a new role at Intuit as VP & General Manager of the Grow Your Business Division.  Angus formerly led Intuit's Mid-Market group as VP & General Manager. Chris Townsend joins i-Nova Software as their VP of Marketing. CORPORATE WHISPERS Hearing from leading CIO's and VP's at technology firms:
  • Many clients refusing to pay maintenance fees and have let contracts lapse
  • Vendors fearful of the high interest in third party maintenance. Some customers considering anti-trust suits in EU and US
  • Virtualization, Business Process Outsourcing, and SaaS seen as cost saving investments
  • Interest in SOA on the decline, but party faithful still in large numbers
  • Gov contracting, healthcare, compliance, project based solutions, and BI remain hot investment sectors for M&A
Got a scoop or something to share? Please post or send on to rwang0 at gmail dot com and we’ll keep your anonymity. * Not responsible for any factual errors or omissions.  However, happy to correct any errors upon email receipt. Copyright © 2009 R Wang. All rights reserved.

Event Report: IBM Unveils the Information Agenda at IOD 2008

(Photo: The show floor from IBM IOD 2008 at the Mandalay Bay Convention Center Copyright © 2008 R Wang. All rights reserved.)

IBM's third annual Information On Demand event emerges as part of the "Must Attend" list of Enterprise Software pow wows.  More than 7000 attendees were treated to 600 technical skill building sessions and 120 business leadership sessions.  This year's theme focused on the need to create an Information Agenda to sustain a competitive advantage and achieve business optimization.  Some interesting perspectives from the event:
  • Business optimization growth is twice as fast than business automation growth. IBM makes the case that workforce productivity, customer profitability, financial risk insight, and other optimization applications gain more traction than automation apps like ERP, HR, Financials, and CRM. POV: The era of automation emphasis is coming to an end.  After years of depositing data into systems, enterprises seek value from all the information in their ERP, CRM, or HR system.  Users expect more than automation from systems and want actionable insight designed for roles that are proactively delivered.
  • IBM is positioned for business optimization via its acquisitions in Information On Demand. The thesis - IBM is delivering information assets via DB2, FileNet, and Informix.  Business value in this trusted information can be unlocked via InfoSphere and then realize optimized business performance via business intelligence (i.e. Cognos). POV: Delivering an Information Agenda requires a tightly integrated stack.  This requires significant integration of canonical data models, business processes, meta data, and semantic information.  While IBM has made progress in bringing together its acquisitions, at this point in time no vendor has truly delivered on this from a software basis.  Considerable amounts of professional services help is still required for success.
Customers See Value In an Information Agenda, now that they know what to call it... As I was there to give talks on integrated data management strategies - Track 2787: The ROI of Instance Consolidation and Track 2792: The Business Value of Integrated Data Management,it was refreshing to find an information focused audience. Here are some interesting conversation snippets and observations:
  • Customers desperately seeking access to "real-time" and "near-time" data from legacy apps.
  • Everyone wants more device delivery choices.
  • The stack war will be Blue vs Red in the next 3 to 5 years.
  • Operational business intelligence critical for actionable insight.
  • BI is not a luxury during a downturn but a necessity for success.
  • Data archiving plays an interesting role in data optimization and meeting compliance requirements
  • MDM continues to gain traction as deal volumes have picked up in Q3 and Q4. This could be the "last big spend" before 2009 as a VP of Apps at a large CPG firm expressed.
Your POV Have you created your own information agenda? Does this term resonate with you? Has your organization shifted from treating data as a commodity to valuing information as an asset? Post a comment or privately reach out to me at rwang0@gmail.com .

(Photo: View from Mix @ THE Hotel during the IBM Cognos reception - IOD 2008 Copyright © 2008 R Wang. All rights reserved.)

Copyright © 2008 R Wang. All rights reserved.